Chen Michael Cunyuan
SEC insider (Form 3/4/5 filer). CIK 0002127529. Chief Scientific Officer at Seaport Therapeutics, Inc. (SPTX). 2 reported Form 4/5 transactions since Sep 2024; latest on May 4, 2026. Located in BOSTON, MA.
Companies Chen Michael Cunyuan has filed insider reports for
- Seaport Therapeutics, Inc. (SPTX): Officer, Chief Scientific Officer
Chen Michael Cunyuan
CIK: 0002127529
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SPTX
Seaport Therapeutics, Inc.
Officer